Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study | BMJ Open Sport & Exercise Medicine

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

Blog

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

XML

Original article

Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Bradwell AR, Ashdown K, Rue C The Birmingham Medical Research Expeditionary Society1 , et al

Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study

BMJ Open Sport & Exercise Medicine 2018;4:e000302. doi: 10.1136/bmjsem-2017-000302